Supplement: Families in Crisis

Families in Crisis Stanley M. Finger The impact of an autoimmune disease is felt by more than just the patient. One of the myths about autoimmune disease is that it has little socioeconomic impact. Nothing could be further from the truth. Autoimmune diseases as a whole afflict many people. In 2005, the National Institutes of Health estimated that as many as 24 million Americans have one or more a

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

One of the myths about autoimmune disease is that it has little socioeconomic impact. Nothing could be further from the truth.

Autoimmune diseases as a whole afflict many people. In 2005, the National Institutes of Health estimated that as many as 24 million Americans have one or more autoimmune disease. This lies between the number of people with cancer (about 10 million) and cardiovascular diseases (about 31 million). Roughly one million new cases of autoimmune disease are diagnosed every year in the United States.

In addition to those demographics, these diseases inflict high medical costs on patients. In 2001, NIH estimated the costs for autoimmune-disease treatments at over $100 billion per year, which is comparable to cancer ($74 billion) and cardiovascular diseases (about $100 billion). The costs of treating autoimmune diseases will surely grow. Some of today's best autoimmune treatments cost as much as $16,000 a year; multiplying that cost ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Stanley M. Finger

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo